🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07288346
Recruiting Not applicable

Effect of Predictive Model on Double-Balloon Enteroscopy

NCT07288346 · tracked via the Priya Life Science China tracker
Sponsor
Shandong University
Phase
Not applicable
Started
2026-01-12
Last updated
2026-01-13

Condition(s) studied

Double-balloon Enteroscopy

Investigational drug(s) / intervention(s)

Predictive model

Predictive model: Endoscopists obtain the patient's predictive model scores before double-balloon enteroscopy.

Study summary

The aim of this study is to assess the effect of predictive model on total enteroscopy rate in double-balloon enteroscopy.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: 1. patients aged between 18 and 80 years who were planned to undergo an attempt at total enteroscopy for suspected small-bowel disease 2. CT scan of the abdomen was performed within two weeks before enteroscopy Exclusion Criteria: 1. cases terminated upon the target lesion (strictures, masses, hemorrhagic or other lesions) and not the maximal insertion 2. poor quality of bowel preparation 3. high risk esophageal varices 4. the insertion route is not oral or anal because of changes in anatomical structure 5. unsuitable for general anesthesia 6. pregnant women 7. unable to provide informed consent

Primary outcome measure(s)

Trial sites (5)

FacilityCityRegionStatus
Dezhou People's Hospital Dezhou Shandong Recruiting
Qilu Hospital of Shandong University (Qingdao) Qingdao Shandong Recruiting
Yantai Affiliated Hospital of Binzhou Medical University Yantai Shandong Recruiting
Zaozhuang Municipal Hospital Zaozhuang Shandong Recruiting
Qilu Hospital of Shandong University Jinan Shangdong Recruiting

More Shandong University trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07288346 on ClinicalTrials.gov ↗ ← All trials in China